Is EC 700-455-1 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EC 700-455-1? Is EC 700-455-1 safe for nursing mother and child? Does EC 700-455-1 extracts into breast milk? Does EC 700-455-1 has any long term or short term side effects on infants? Can EC 700-455-1 influence milk supply or can EC 700-455-1 decrease milk supply in lactating mothers?
Answer by DrLact: About EC 700-455-1 usage in lactation
No information is available on the clinical use of EC 700-455-1 during breastfeeding. Because EC 700-455-1 is 96% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 22 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during EC 700-455-1 therapy.
Alternate Drugs
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Cladribine(Dangerous)
Mercaptopurine(Safe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Cetuximab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)